Search - tctmd.com

Displaying 81 - 100 of 4560

Sort: Relevancy | Date

Presentation TCT 2016

TCT 402: Relationship Between Bioresorbable Scaffold Sizing and Scaffold Thrombosis: A Pooled Analysis of ABSORB Trials

Presenter: Serban Puricel, Clemens von Birgelen

November 01, 2016

Presentation TCT 2016

Percutaneous Coronary Intervention with the ANgiolite Drug-Eluting Stent: an Optical CoHerence TOmogRaphy Study. The ANCHOR Study

Presenter: Fernando Alfonso, Ran Kornowski, Josep Rodés-Cabau

November 01, 2016

Presentation TCT 2016

Case #6: No Guessing Needed Using OCT for This Bifurcation

Presenter: Henning Kelbæk

November 01, 2016

Presentation TCT 2016

Case #5: This is Why OCT is Encouraged by EBC for Complex Bifurcations

Presenter: Jens Flensted Lassen

November 01, 2016

Presentation TCT 2016

Case #4: Where are the Guide Wires? Two-stent Treatment by OCT

Presenter: Hannu Romppanen

November 01, 2016

Presentation TCT 2016

Case #3: Simple Stenting With a Kiss and OCT

Presenter: Julian Strange

November 01, 2016

News Industry News TCT 2016

Dedicated Stent Study Conducted in Women and Minority Assesses Risks of Adverse Cardiovascular Events Following Coronary Stent Procedures

November 01, 2016

News Industry News

Sudy Indicates PCI Of NIRS-Defined Lipid-Rich Plaque Is Safe And Not Associated With A Greater Incidence Of Adverse Outcomes Compared To PCI of Non Lipid-Rich Plaque

November 01, 2016

Presentation TCT 2016

BRS Snapshots: A Novel Biodegradable FE/316L Stent

Presenter: Ron Waksman, Robert-Jan van Geuns, Olivier F. Bertrand

October 31, 2016

Presentation TCT 2016

Biodegradable Scaffolds In STEMI: Rationale, Registry outcomes (Literature search) and TROFI II 2-year Results

Presenter: Deepak L. Bhatt, Stefan K. James, Manel Sabate

October 31, 2016

Presentation TCT 2016

Metallic DES in STEMI: Are There Experimental or Clinical Differences Between Devices?

Presenter: Deepak L. Bhatt, Stefan K. James, Tullio Palmerini

October 31, 2016

Presentation TCT 2016

Debate: Is PCI Standard of Care in Left Main Disease After EXCEL and NOBLE? No - So Many Questions Are Still Unanswered!

Presenter: Robert A. Guyton, Martin B. Leon, Marc Ruel

October 31, 2016

Presentation TCT 2016

Is There a Current Role for Intracoronary Lytics or GP IIb/IIIa Inhibitors During Primary PCI?

Presenter: Deepak L. Bhatt, Stefan K. James, C. Michael Gibson

October 31, 2016

Presentation TCT 2016

Debate: Is PCI Standard of Care in Left Main Disease After EXCEL and NOBLE? Yes the Issue Is No Longer in Doubt!

Presenter: Robert A. Guyton, Martin B. Leon, David E. Kandzari

October 31, 2016

Presentation TCT 2016

Trial #8 - The Essentials ofThe ACT I Trial: Carotid Stenting vs Surgery In Asymptomatic Patients

Presenter: William A. Gray, Stephan Windecker, Kenneth Rosenfield

October 31, 2016

Presentation TCT 2016

Debate: Does Radial Access Really Improve Survival for STEMI? Yes - Radial Intervention for STEMI Improves Survival and Should Be Standard Practice!

Presenter: Deepak L. Bhatt, Stefan K. James, Michael A. Kutcher

October 31, 2016

Presentation TCT 2016

OCT-guided vs Angio-guided Left Main Treatment: Rationale and Design of the OCTOBER Trial

Presenter: Evald H. Christiansen, Per Hostrup Nielsen, Niels R. Holm

October 31, 2016

Presentation TCT 2016

SYNTAX Stratified NOBLE Results

Presenter: Evald H. Christiansen, Per Hostrup Nielsen, Ian Menown

October 31, 2016

Presentation TCT 2016

New Insights Into Thrombus Aspiration for STEMI: Results From the TOTAL Angiographic Core Lab

Presenter: Deepak L. Bhatt, Stefan K. James, Christopher Overgaard

October 31, 2016

Presentation TCT 2016

NOBLE Left main Bifurcation Stent Techniques

Presenter: Evald H. Christiansen, Per Hostrup Nielsen, Mitchell Lindsay

October 31, 2016

Advertisement

TCT 402: Relationship Between Bioresorbable Scaffold Sizing and Scaffold Thrombosis: A Pooled Analysis of ABSORB Trials

Percutaneous Coronary Intervention with the ANgiolite Drug-Eluting Stent: an Optical CoHerence TOmogRaphy Study. The ANCHOR Study

Case #6: No Guessing Needed Using OCT for This Bifurcation

Case #5: This is Why OCT is Encouraged by EBC for Complex Bifurcations

Case #4: Where are the Guide Wires? Two-stent Treatment by OCT

Case #3: Simple Stenting With a Kiss and OCT

Dedicated Stent Study Conducted in Women and Minority Assesses Risks of Adverse Cardiovascular Events Following Coronary Stent Procedures

Sudy Indicates PCI Of NIRS-Defined Lipid-Rich Plaque Is Safe And Not Associated With A Greater Incidence Of Adverse Outcomes Compared To PCI of Non Lipid-Rich Plaque

BRS Snapshots: A Novel Biodegradable FE/316L Stent

Biodegradable Scaffolds In STEMI: Rationale, Registry outcomes (Literature search) and TROFI II 2-year Results

Metallic DES in STEMI: Are There Experimental or Clinical Differences Between Devices?

Debate: Is PCI Standard of Care in Left Main Disease After EXCEL and NOBLE? No - So Many Questions Are Still Unanswered!

Is There a Current Role for Intracoronary Lytics or GP IIb/IIIa Inhibitors During Primary PCI?

Debate: Is PCI Standard of Care in Left Main Disease After EXCEL and NOBLE? Yes the Issue Is No Longer in Doubt!

Trial #8 - The Essentials ofThe ACT I Trial: Carotid Stenting vs Surgery In Asymptomatic Patients

Debate: Does Radial Access Really Improve Survival for STEMI? Yes - Radial Intervention for STEMI Improves Survival and Should Be Standard Practice!

OCT-guided vs Angio-guided Left Main Treatment: Rationale and Design of the OCTOBER Trial

SYNTAX Stratified NOBLE Results

New Insights Into Thrombus Aspiration for STEMI: Results From the TOTAL Angiographic Core Lab

NOBLE Left main Bifurcation Stent Techniques

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content